An interventional study of Uterine Ablation in Heavy Uterine Bleeding, sponsored by Female Pelvic Medicine & Urogynecology Institute of Michigan. Completed at 1 site in United States. Open to female participants aged 30 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2013-08-14.
Sponsored by Female Pelvic Medicine & Urogynecology Institute of Michigan · Not applicable and Interventional
Investigational study to determine if an endometrial ablation for heavy uterine bleeding, can be tolerated in the office setting without the use of intravenous medication.
A safe and effective treatment , called endometrial ablation, has been used in a hospital setting under general anesthesia for the treatment of heavy uterine bleeding. This study will evaluate if patients would tolerate the same procedure in an office setting using local anesthetics and common pain medication. This study will include twenty patients.
156 studies on the registry are indexed under Uterine Hemorrhage; 19 are open to participants now.
This study's enrollment of 21 is below the median of 96 across 111 interventional studies indexed under Uterine Hemorrhage.
Browse Uterine Hemorrhage studies →This is the only study on the registry with Female Pelvic Medicine & Urogynecology Institute of Michigan as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Uterine Ablation in the office setting to see if the procedure is tolerated w/o sedation
Tolerability of Uterine Ablation in the office setting
Time frame: 30 days
This study is completed, as verified in Aug 2013. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.